v3.26.1
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Operating Activities:        
Net loss $ (2,292,922) $ (1,879,055) $ (8,951,121) $ (8,609,156)
Adjustments to reconcile net loss to net cash used in operating activities:        
Amortization and depreciation 72,445 96,366 389,281 385,464
Non-cash lease expense 27,136 24,314 101,357 90,976
Amortization of debt discounts     0 237,250
Non-cash interest expense 1,145 0 8,141 204,043
Stock-based compensation expense 7,243 139,678 485,432 729,712
Non-cash conversion expense     0 585,875
Bad debt expense 9,022 0 16,203 25,260
Non-cash disposal of obsolete inventory     0 115,741
Non-cash asset impairment loss     456,377 0
Changes in assets and liabilities:        
Accounts receivable 4,281 (4,146) (27,650) (24,440)
Inventory 4,300 31,007 78,353 2,166
Prepaid expenses 60,338 3,155 197,919 284,690
Other assets 5,090 23,675 24,689 (46,060)
Accounts payable 8,567 (10,055) 62,174 (103,108)
Accrued expenses (492,471) (105,998) 304,322 (311,403)
Accrued interest payable 314 2,124 1,259 8,513
Deferred revenue 24,648 0 6,600 0
Operating lease liabilities (30,337) (26,562) (111,303) (97,107)
Net cash used in operating activities (2,591,201) (1,705,497) (6,957,967) (6,521,584)
Investing Activities:        
Purchase of property and equipment     (38,172) 0
Net cash used in investing activities     (38,172) 0
Financing Activities:        
Repayments of notes payable - non-related parties (61,764) (100,907) (250,421) (200,808)
Proceeds from exercise of stock warrants 68 3,680,411 3,680,411 5,340,747
Payment for transaction costs of equity transactions 0 (184,020) (418,458) (1,224,456)
Proceeds from notes payable - non-related parties       0
Proceeds from private equity offering     1,999,935 8,199,996
Payment of 2024 PIPE Warrant True-up Payment     (1,640,000) 0
Net cash provided by (used in) financing activities (61,696) 3,395,484 3,371,467 12,115,479
Net Change In Cash (2,652,897) 1,689,987 (3,624,672) 5,593,895
Cash At The Beginning Of The Period 4,759,370 8,384,042 8,384,042 2,790,147
Cash At The End Of The Period 2,106,473 10,074,029 4,759,370 8,384,042
Schedule Of Non-Cash Investing And Financing Activities:        
Non-related party debt converted to capital     0 2,879,279
Deemed dividends related to original warrants and new warrants down round provision     0 1,541,833
Deemed dividends related to 2022 PIPE Warrants down round provision 0 1,547 1,547 46,875
Deemed dividends related to Convertible Debt Warrants down round provision 0 1,833 1,883 23,270
Deemed dividends related to 2024 PIPE Warrants down round provision 0 47,373 47,373 0
Value of exercise price reduction related to warrant inducement     0 341,297
Financing of prepaid insurance premiums     0 264,066
Issuance of common stock and warrants for prepaid services     0 0
Supplemental Disclosure:        
Cash paid for interest 2,006 1,541 $ 12,377 $ 32,579
Cash paid for income taxes $ 0 $ 0